Participant-centric Trial Will Test if Antiviral Paxlovid Ca

Researchers are still in the dark on the mechanisms underlying and how to treat long COVID. A new clinical trial using the oral antiviral Paxlovid will provide

Related Keywords

Akiko Iwasaki , Haroldh Hines Jr , Harlan Krumholz , Hugo Health , Institute For , Policy Studies , Sterling Professor , Persistence Is One , Several Long , Accessible Design , Professor Krumholz , Professor Iwasaki ,